p21
waf1 has been shown to mediate the p53-dependent growth arrest induced by DNA-damaging agents. Several functions have been ascribed to p21 waf1 that could be involved in this growth arrest. For one, p21
waf1 is an ecient inhibitor of cyclin-dependent kinases (CDKs). Also, p21
waf1 can interact with proliferating cell nuclear antigen (PCNA), and as such inhibit in vitro DNAreplication. Finally, p21 waf1 has been reported to inhibit stress-activated protein kinases (SAPKs). In order to study these multiple functions of p21 waf1 we have established U2OS-derived cell lines, in which the expression of p21 waf1 can be regulated by the concentration of tetracycline in the culture medium. We observed a virtually complete, but reversible inhibition of cell growth upon induction of p21 . Upon induction of p21 waf1 cells accumulated with a 2N or 4N DNA content suggesting events in G1 and G2 can be inhibited by p21 waf1 . Indeed, kinase activity associated with cyclin B was reduced dramatically upon induction of p21 waf1 , although cyclin B continues to be expressed. In contrast, p21 waf1 does not seem to inhibit the function of PCNA in ongoing DNA replication, since cells expressing high levels of p21 waf1 apparently progressed normally through S-phase. Also, the activity of SAPKs was not substantially aected by the high levels of p21 waf1 . We conclude that, at least in these U2OS-derived cells, p21
Introduction
Orderly progression of cells through the mammalian cell cycle is dependent on the sequential activation of speci®c cyclin-dependent kinases (CDKs) (Draetta, 1993; Hunter and Pines, 1994; Sherr, 1994) . The activation of these cyclin-dependent kinases is a complex event for which many regulatory mechanisms exist. For one, the enzymatic activity of a CDK is strictly dependent on association with its cognate cyclin. Expression of these cyclins is regulated in a cell cycle-dependent fashion, giving rise to temporal activation of each CDK. Upon association with the cyclin subunit, the CDK subunit can be phosphorylated on a conserved threonine residue, resulting in its activation (Solomon, 1994; Morgan, 1995) . Also, inhibitory phosphate groups on the CDK need to be removed by speci®c phosphatases for its full activation (Morgan, 1995) .
An additional level of regulation became apparent with the identi®cation of speci®c inhibitor proteins of the cyclin-dependent kinases (CKIs). Several CKIs have been identi®ed that can inhibit active cyclin/ CDK complexes either by stoichiometric binding or by dissociating the complex. CKIs fall into two families, one comprised of p21 waf1 , p27 kip1 and p57 kip2 , the other of p15 ink4b , p16 ink4a , p18
ink4c and p19 ink4d (Sherr and Roberts, 1995) . The p16 ink4a -family of inhibitors speci®cally interferes with cyclin D-dependent kinase activity through competition with cyclin D for binding to CDK4 and CDK6 (Sherr and Roberts, 1995) . The p21 waf1 family of inhibitors appears to function on a broader spectrum of CDKs and inactivates cyclin/ CDK complexes by stoichiometric binding (Morgan, 1995) . p21 waf1 was originally identi®ed as an inhibitor of CDK2, CDK4 and CDC2 kinase complexes (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993) . More recently, it was shown that p21 waf1 can also inhibit CDK3 and CDK6 kinases, and that p21 waf1 is most eective toward G1/S cyclins . Indeed p21 waf1 can cause a cell cycle arrest in a variety of cell lines when overexpressed in transiently transfected cells (Guan et al., 1994; Harper et al., 1995; Medema et al., 1995) , suggesting it can interfere with cyclin-dependent kinase activity in intact cells. In addition, it was shown that p21 waf1 is a transcriptional target of p53, and that expression of p21 waf1 is strongly induced by DNA damage in cells expressing functional p53 (El-Deiry et al., 1993 , 1994 Dulic et al., 1994) .
p53 is an important mammalian tumor suppressor gene (Hinds and Weinberg, 1994; Cox and Lane, 1995) and mutations in the p53 gene are the most commonly observed genetic lesion in human tumors (Hollenstein et al., 1991) . In response to genotoxic stress such as DNA-damage, p53 protein levels increase through stabilization of the protein, resulting in a G1 arrest (Kastan et al., 1991 (Kastan et al., , 1992 Livingstone et al., 1992; Yin et al., 1992) or apoptosis (Clarke et al., 1993; Lowe et al., 1993) . In addition, p53 has been reported to be involved in the spindle checkpoint which controls proper separation of the chromosomes during cell division (Cross et al., 1995) . Using p21 waf1 -nullizygous mice, p21 waf1 was shown to be required for the p53-dependent G1-arrest observed after in¯icting DNA damage (Brugarolas et al., 1995; Deng et al., 1995) . Other aspects of p53, such as apoptosis and the spindle checkpoint were not aected in p21 waf1 -nullizygous cells, suggesting that these do not require p21 waf1 . Activation of p21 waf1 -expression can also occur independent of p53. Induction of p21 waf1 independent of p53 has been observed following TGF-b stimulation (Datto et al., 1995; Reynisdottir et al., 1995) , during dierentiation (Jiang et al., 1994; Michieli et al., 1994; Steinman et al., 1994; Guo et al., 1995; Halevy et al., 1995; Macleod et al., 1995; Missero et al., 1995; Parker et al., 1995) or upon cellular senescence (Noda et al., 1994) . In each of these cases, the upregulation of p21 waf1 correlates with an arrest in cell proliferation, suggesting it could be the mediator of dierent growthinhibitory signals.
Obviously, p21 waf1 could mediate the arrest in proliferation through inhibition of the cyclin-kinase complexes required to make certain cell cycle transitions. On the other hand, p21
waf1 was shown to bind the proliferating cell nuclear antigen (PCNA) which is involved in DNA-replication and repair (Flores-Rozas et al., 1994; Waga et al., 1994) . p21
waf1 caused an inhibition of DNA-replication in vitro, whereas in vitro DNA-repair was not aected . Thus, induction of p21 waf1 could lead to an inhibition of cyclin/kinase complexes combined with an inhibition of DNA-replication. This dual function of p21 waf1 could ensure an ecient block of cell cycle progression upon induction of p21 waf1 . Recently, a third function for p21 waf1 was proposed, when it was shown that it can inhibit stress-activated kinases (SAPKs), also known as the c-Jun aminoterminal kinases (JNKs) (Shim et al., 1996) . Both in vitro, as well as in transiently transfected cells, p21 waf1 could cause a very signi®cant reduction of SAPKactivity associated with the a, b and the g isoforms. This family of kinases is activated in response to cellular stress caused by a variety of agents, such as DNA-damaging agents, protein synthesis inhibitors, heat shock and tumor-necrosis factor-a (Kyriakis et al., 1994) . Remarkably, some of the events that can activate SAPKs, such as DNA damage, will also induce p21 waf1 . This could indicate that a negative feedback loop exists, where a rapid induction of SAPK-activity is followed by downregulation through induction of p21 waf1 .
Here we wanted to study each of these possible functions of p21 waf1 . In order to study the eect of p21 waf1 independent of agents which generally inhibit cell cycle progression we established p21 waf1 -inducible cell lines. To this end, we made use of the tetracyclinerepressible system to drive expression of p21 waf1 (Gossen and Bujard, 1992) . We observed a dramatic reduction in the growth of these cells upon switching on p21 waf1 -expression. Interestingly, although the level of p21 waf1 obtained in our cells is comparable to what is observed after treatment of these cells with ionizing radiation, no inhibition of ongoing DNA-synthesis can be observed. This indicates that at least in these cells the levels of p21 waf1 reached in vivo are not sucient to inhibit the function of PCNA in ongoing DNAreplication. Also, no substantial inhibition of SAPKs was observed after induction of p21 waf1 , whereas CDK2-activity was reduced to background levels, suggesting that SAPKs are not a target of p21 waf1 in vivo. Furthermore, we found that induction of p21 waf1 in asynchronous cultures caused cells to accumulate in the G1 and G2/M phases of the cell cycle and resulted in a reduction in cyclin B-associated kinase activity, indicating that both G1 as well as G2 cyclin-kinase complexes are inhibited by p21 waf1 under these conditions.
Results

Inducible expression of p21 waf1
To obtain cells in which the expression of p21 waf1 could be regulated independently of p53 we utilized the tetracycline-repressible system. This system makes use of a hybrid protein containing the tetracycline repressor from bacteria fused to the transactivating domain of virion protein 16 of herpes simplex virus (Gossen and Bujard, 1992) . This recombinant transactivator (tTA) can stimulate transcription from control elements of the tetracycline-resistance (tet) operon. However, DNA-binding by tTA is blocked by tetracycline. Thus, tTA can stimulate expression from tet operator sequences in the absence of tetracycline, whereas no transactivation will occur in the presence of tetracycline (Gossen and Bujard, 1992) .
A U2OS osteosarcoma-derived cell line was obtained in which tTA is stably expressed (UTA6) (Englert et al., 1995) . These cells express functional retinoblastoma protein (pRB) and p53 (Diller et al., 1990) . UTA6 cells were subsequently transfected with an expression plasmid containing the human p21 waf1 cDNA, under control of a minimal CMV promoter fused to tetracycline operator sequences. Colonies were picked and analyzed for inducible expression of p21 waf1 . Two clones, UTA21.9 and UTA21.15, expressed very little p21 waf1 when cultured in the presence of 1 mg/ml tetracycline, whereas p21 waf1 expression was dramatically induced upon removal of tetracycline from the culture medium (Figure 1a ). p21 waf1 protein was detectable in these cells after 4 h of tetracycline-free culture (not shown) and continued to rise up to 72 h ( Figure 1b) .
Next, we wanted to compare the protein levels of p21 waf1 produced by the tetracycline-repressible system to those obtained after in¯icting DNA damage. This can be done in U2OS-derived cells, since the function of p53, required for induction of p21 waf1 by DNA damage, is retained in these cells. We activated this pathway using ionizing radiation or addition of camptothecin to the culture medium, which inhibits DNA topoisomerase resulting in double stranded DNA-breaks. When UTA21.15 cells were irradiated with ionizing radiation we observed an increase in the level of p21 waf1 , con®rming this functionality of p53 (Figure 1b) . At 24 h after removal of tetracycline levels of p21 waf1 were comparable to those obtained by ionizing radiation (Figure 1b) . As a further control we added camptothecin to the parental UTA6 cells in a range of concentrations to determine the optimal level of p21 waf1 that could be obtained through DNAdamage. Maximal induction of p21 waf1 was achieved at 1.2 mM camptothecin (Figure 1c) . Again, the maximal levels of p21 waf1 achieved with camptothecin were comparable to the levels seen in the UTA21.15 cells grown without tetracycline (Figure 1c) . Thus, these cell lines express sucient p21 waf1 to investigate its role in growth inhibition, independent of activation of p53. (Figure 2a) . No eect of removal of tetracycline was observed in the control cell line, UTApuro1 (Figure 2a) . In addition, when we examined the proliferation of these cells over a period of several days, we observed an almost complete inhibition of cell proliferation in the UTA21.15 cells upon removal of tetracycline from the culture medium (Figure 2b ). In contrast, the growth curve of UTA21.15 cells grown in the presence of tetracycline was indistinguishable of that of the control cells (Figure 2b) . The arrested cells re-entered the cell cycle when tetracycline was added back to the culture medium at 3 or 5 days (Figure 2c ), indicating that the p21 waf1 -induced cell cycle arrest is reversible.
Inhibition of cyclin A-and E-dependent kinase activity by p21 waf1
To study whether the expressed p21 waf1 would aect CDK-activity, we measured CDK2 kinase activity. For this purpose, cells cultured in the presence or absence of tetracycline were lysed and CDK2 was immunoprecipitated. Immunocomplexes were used in in vitro kinase reactions, with histone H1 as a substrate. Figure 3a shows that CDK2-kinase activity is reduced to background levels upon induction of p21 waf1 in the UTA21.9 and UTA21.15 cells. In contrast, the CDK2-activity in the control cell line UTApuro1 was unaected by removal of tetracycline from the culture that is obtained in the UTA21.9 and UTA21.15 cells is sucient to block the activity of the endogenous cyclin-CDK2 complexes. Since CDK2 can form an active kinase complex by association with cyclin E or A, this would suggest that both cyclin E-and cyclin Aassociated kinase activity are inhibited in these cells. However, since cyclin A is the principal driver of CDK2-kinase activity one could speculate that the observed inhibition of CDK2-kinase activity is solely due to a lack of cyclin A protein. Therefore, we also examined cyclin E-associated kinase activity. Again, a sharp reduction in kinase activity was observed in cyclin E-immunoprecipitates in UTA21.15 cells grown without tetracycline (Figure 3b ). This reduction was not due to a lack of cyclin E/CDK2 complexes since the levels of cyclin E and CDK2 protein were unaltered as determined by Western blot analysis (not shown). Also, we did not observe a reduction in the amount of CDK2 in cyclin E-immunoprecipitates from cells grown in the absence of tetracycline (data not shown), indicating p21 waf1 does not interfere with the formation of the cyclin E/CDK2 complex.
Eect of p21
waf1 on stress-activated protein kinases
Recently, it was shown that p21 waf1 can inhibit the a, b and g isoforms of SAPK, both in vitro as well as in transiently transfected cells (Shim et al., 1996) . Therefore, we wanted to investigate if such an inhibition would also take place at the expression levels of p21 waf1 obtained with the tetracycline-repressible system. To do so, UTA21.15 cells were cultured in the presence or absence of tetracycline. SAPKs were then activated by treatment with anisomycin, sorbitol, cyclohexamide or u.v.-irradiation. SAPKs were subsequently precipitated using an antibody recognizing the a, b and g isoforms of SAPK and in vitro kinase reactions were performed with GST-c-jun as a substrate. SAPK-activity increased several-fold (6 ± 126) in response to the various treatments ( Figure 4 , lower panels). All stressactivating stimuli we used caused an approximately twofold reduction in the CDK2-activity (Figure 4 , upper panels), indicating that stress-inducing agents can downregulate CDK2-activity within 30 min. Remarkably, SAPK-activity was not signi®cantly aected by high levels of p21 waf1 (Figure 4 ), whereas CDK2-activity was reduced to background levels (a 40-fold reduction) within the same cell lysates. We also examined whether the overall expression of SAPKs was altered by removal of tetracycline from the culture medium, but found no changes in the level of SAPKs using Western blot analysis (data not shown). These data indicate that, although sucient p21 waf1 is present to inhibit CDK2-associated kinase activity, p21 waf1 does not function as an inhibitor of SAPKs in these cells.
p21
waf1 blocks cells at two points in the cell cycle
Transient expression of p21 waf1 in U2OS cells has been shown to result in a G1-arrest (Guan et al., 1994; Medema et al., 1995) , but the eect of p21 waf1 on progression through G2/M is still unclear. It is not unlikely that p21 waf1 can arrest cells at the G2/M transition, since it can inhibit cyclin-kinase complexes that are active in G2/M (Xiong et al., 1993) . Therefore, we tried to establish in which phase of the cell cycle p21 waf1 exerts its growth-inhibitory eect. To do so, we analysed cell cycle pro®les of these cells using bivariatē ow cytometry. Cells were pulsed with bromodeoxyuridine (BrdU) for 10 min to determine the fraction of cells in S-phase and counterstained with propidium iodide to distinguish cells in G1 or G2/M. Indeed, when tetracycline was removed from asynchronous cultures for dierent periods of time, cells seemed to arrest with a 2N or 4N DNA-content (Figure 5a and b). This growth arrest ®rst becomes evident around 24 h after removal of tetracycline, and at 48 h virtually all cells have arrested with a 2N or 4N DNA-content (*3% BrdU-positive) and appear to remain in this arrested state for at least another 24 h (Figure 5a and b). This would suggest that p21 waf1 can aect the G2/M transition as well. However, since these cells are tumorderived cells it is also possible that a large proportion of these cells are tetraploid, and as a consequence would arrest in G1 with a 4N DNA-content. To rule out this latter possibility, we synchronized these same . Cells were seeded with or without tetracycline and cultured for 24 h. Cells were then lysed and CDK2 or cyclin E were immunoprecipitated as described in Materials and methods. Immunocomplexes were used for in vitro kinase reactions with histone H1 as substrate. Equal amounts of protein were used in each immunoprecipitation. (a) CDK2-activity immunoprecipitated from UTApuro1 (lanes 1 and 2), UTA21.9 (lanes 3 and 4) and UTA21.15 (lanes 5 and 6) grown in the presence (lanes 2, 4 and 6) or absence (lanes 1, 3 and 5) of tetracycline. 1 and 3) . For analysis of cyclin Bassociated kinase activity, cells were lysed and cyclin B was immunoprecipitated. Immunocomplexes were then used in an in vitro kinase reaction with histone H1 as substrate. (d) Cyclin B protein levels in UTApuro1 (lanes 1 and 2) or UTA21.15 cells (lanes 3 and 4) grown in the presence (lanes 2 and 4) or absence of tetracycline for 24 h (lanes 1 and 3) . Cyclin B protein levels were determined by Western blotting (e) Immunoprecipitates of cyclin B (lanes 1 and 2) inhibits cyclin B/CDC2 complexes. To investigate this possibility we studied the eect of p21 waf1 on cyclin Bassociated kinase activity. For this purpose, cyclin B was immunoprecipitated from lysates prepared from UTApuro1 and UTA21.15 cells grown in the presence or absence of tetracycline. These immunocomplexes were then used in in vitro kinase reactions, with histone H1 as a substrate. We found a dramatic reduction in cyclin B-associated kinase activity in the UTA21.15 cells induced to express p21 waf1 ( Figure 5c ) after 24 h in tetracycline-free medium. To rule out that this inhibition of cyclin B-associated kinase activity was due to a reduction in cyclin B protein levels we determined the levels of cyclin B protein by Western blotting. No dierence in the levels of cyclin B expression were detected (Figure 5d ), suggesting that the inhibition of cyclin B/CDC2 complexes is through binding of p21 waf1 to this latter complex. To investigate if p21
waf1 could associate to cyclin B under these conditions, we metabolically labeled UTA21.15 cells with 35 S-methionine and immunoprecipitated both cyclin B and p21 waf1 . As is shown in Figure 5e , a protein corresponding in size with cyclin B coimmunoprecipitated with p21 waf1 . We could detect more of this protein in cells expressing high levels of p21 waf1 , indicating it was a true co-immunoprecipitating protein. Also, in the reverse experiment, a protein of the size of p21 waf1 could be detected in cyclin Bimmunoprecipitates and again more of this protein was present in immunocomplexes from cells expressing high levels of p21 waf1 . These ®ndings strongly suggest that cyclin B/CDC2 complexes are inhibited by p21 waf1 in vivo through stochiometric binding of p21 waf1 to cyclin B/CDC2 complexes.
waf1 does not inhibit progression through S-phase p21 waf1 has the ability to inhibit DNA replication in vitro through binding to PCNA. Thus, it has been speculated that the abrogation of DNA-synthesis which occurs upon DNA damage in¯icted by ionizing radiation could be a consequence of this function of p21 waf1 . In order to investigate such a role of p21 waf1 , we examined whether progression through S-phase was impaired in the UTA21.15 cells induced to express p21 waf1 . To do so, cells were pulsed with BrdU for 10 min after which BrdU was washed away and cells were allowed to grow for dierent periods of time. This way, we were able to follow the BrdU-positive cells as they passed through S-phase. From our previous experiments we estimated that induction of p21 waf1 -expression for 24 h would result in complete inhibition of CDK2-kinase activity (Figure 3a) , whereas a signi®cant fraction of cells would still be in S-phase ( Figure 5) . Indeed, after 24 h in tetracycline-free medium we observe a reduction in the number of BrdU-positive cells. In addition, the largest fraction of BrdU-positive cells seem to be present in early-S when expression of p21 waf1 is low (Figure 6a : t=0, +tet). This in contrast to cells expressing high levels of p21 waf1 , where BrdU-positive cells are evenly distributed throughout S-phase (Figure 6a: t=0, 7tet) , demonstrating that S-phase entry is reduced in these cultures. As is evident from Figure 6a , most BrdU-positive cells have completed S-phase around 10 h after the initial BrdU-pulse. More importantly, we could not observe any dierence in the rate at which cells completed Sphase when p21 waf1 -expression was induced. To con®rm inhibition of CDK-activity by p21 waf1 under these conditions, we determined CDK2-kinase activity by in vitro kinase assay using these same cells. At the zero time-point of the BrdU pulse-chase experiment ( Figure  6b , lanes 1 and 2) we ®nd an inhibition of CDK2-activity that is very similar to what is observed at later time-points (Figure 6b , lanes 3 to 6), demonstrating that induction of p21 waf1 expression for 24 h is sucient to fully inhibit CDK2-activity. Therefore, the lack of eect of p21 waf1 on progression through S-phase is apparently not due to a partial inhibition of CDK2. These data demonstrate that p21 waf1 does not aect processive DNA-replication, a process in which PCNA is assumed to play an important role (Kelman, 1997) . Therefore, we ®nd no support for a mechanism in which p21 waf1 would stall DNA-replication through interference with the function of PCNA in order for DNA-repair to take place. This lack of inhibition could be a consequence of a lack of binding of p21 waf1 to PCNA. To study this, we again metabolically labeled UTA21.15 cells and immunoprecipitated p21 waf1 and PCNA. Immunocomplexes obtained with an anti-PCNA monoclonal antibody contained a small amount of a protein comigrating with p21 waf1 , but only when prepared from cells expressing high levels of p21 waf1 (Figure 5d ). Vice versa, a protein comigrating with PCNA was detected in p21 waf1 -immunoprecipitates, in addition to several other proteins with similar mobility, possibly cyclin D1 and CDKs (Figure 5d ). This would indicate that p21 waf1 can form a complex with PCNA under these circumstances, although it is not immediately evident whether this is through binding of cyclin/CDK complexes that also contain PCNA, or by direct binding of p21 waf1 to PCNA. In order to estimate the fraction of PCNA bound to p21 waf1 , we carried out a depletion experiment, in which lysates were cleared for p21 waf1 by immunoprecipitation. Subsequently, the cleared supernatants were used to immunoprecipitate PCNA and compared with noncleared lysates. Depletion of p21 waf1 resulted in a very marginal loss of PCNA from these lysates (Figure 5c ) and from these data it could be quanti®ed that at 510% of PCNA is bound to p21 (lanes 1 and 2) , and t=12 (lanes 3 and 4) time-points grown with (lanes 2 and 4) or without tetracycline (lanes 1 and 3) as described in a and from UTA21.15 grown for 48 h with (lane 5) or without tetracycline (lane 6). CDK2 activity was determined as described in the legend to Figure 4 . (c) Immunoprecipitation of PCNA from metabolically labeled UTA21.15 cells grown with (lanes 3 and 4) or without tetracycline (lanes 1 and 2). PCNA was either precipitated directly (lanes 1 and 2) or lysates were precleared by two subsequent immunoprecipitations with an anti-p21 waf1 polyclonal antibody after which PCNA was precipitated from the remaining supernatant (lanes 3 and 4). Immunoprecipitates were washed, boiled and analysed on PAA gels. S-methionine for 3 h. After labeling cells were lysed and PCNA or p21 waf1 was immunoprecipitated. Immunocomplexes were analysed on a 8 ± 15% PAA gradient gel p21 can block cells at two points in the cell cycle RH Medema et al cells seem to be able to complete mitosis in the cultures expressing high levels of p21 waf1 (Figure 6a : t=12, 7tet), again indicating that p21 waf1 can cause cells to arrest in the G2-phase.
Discussion
Here we have studied the function of p21 waf1 using inducible cell lines in which the expression of p21 waf1 can be regulated by the amount of tetracycline in the culture medium. We used a U2OS-derived cell line stably expressing the tetracycline-repressor fusion protein (Englert et al., 1995) . These cells have been shown to express functional pRB and functional p53 (Diller et al., 1990) . We obtained two independent clones that can be induced to express high levels of p21 waf1 upon removal of tetracycline from the culture media. The total amount of p21 waf1 expressed in these cells when cultured in tetracycline-free medium for 24 h is similar to the amount of p21 waf1 expressed after ionizing radiation or treatment with camptothecin, and therefore these cells could be used to study the eect of expressing physiological levels of p21 waf1 independent of p53. Upon induction of p21 waf1 -expression we observed a change in morphology reminiscent of the¯at cell phenotype observed when pRB is expressed in SAOS-2 cells ( (Hinds et al., 1992) , data not shown) and a virtually complete inhibition of cell growth. In addition, we found a dramatic reduction in waf1 on cell growth is reversible, since re-addition of tetracycline results in a rapid recovery of the cells. Twenty-four hours after readdition of tetracycline cells have re-entered the cell cycle. The fact that cells will re-enter the cell cycle if tetracycline is added back after 5 days of tetracyclinefree culture indicate that no secondary changes have occurred in response to the p21 waf1 -induced cell cycle arrest that can prevent this reversion.
In accordance with the proposed function of p21 waf1 as an inhibitor of cyclin-kinase complexes, we ®nd a dramatic inhibition of CDK2-associated kinase activity in cells expressing high levels of p21 waf1 . This inhibition could be an indirect eect of a block in cell cycle progression somewhere in G1, resulting in a reduction of cyclin A protein levels. However, cyclin E-associated kinase activity was found to be similarly inhibited, whereas protein levels of cyclin E and CDK2 where unaltered (not shown).
In addition to the CDKs, SAPKs have also been shown to be inhibited by p21 waf1 both in vitro as well as in cells cotransfected with p21 waf1 -and SAPK-expression vectors (Shim et al., 1996) . The inhibitor constants (K i ) for SAPKb and CDK2 were found to be very similar; 7.5610 78 M and 1.7610 78 M, respectively. However, it has not been established whether the inhibition of SAPKs can also occur with physiological levels of p21 waf1 . Also, it is not immediately evident what the signi®cance of such an inhibition of SAPKs by p21 waf1 would be, since both activation of SAPKs as well as an increase in the level of p21 waf1 can occur by one and the same signal, such as DNA-damage. To our surprise, we could not detect a substantial inhibition of the sorbitol-, cyclohexamide-, u.v.-or anisomycininduced SAPK-activity by p21 waf1 , whereas the CDK2-associated activity was inhibited to basal levels within the same lysates. Since the levels of p21 waf1 obtained in these cells are comparable to what is obtained by ionizing radiation, this indicates that, at least in these cells, SAPKs are not inhibited by physiological levels of p21 waf1 . A third function that has been ascribed to p21 waf1 is based on its ability to interact with PCNA (Xiong et al., 1992) . PCNA is an essential auxiliary factor required for the function of DNA polymerase d. Using in vitro assays it was shown that p21 waf1 can inhibit PCNAdependent DNA-replication (Flores-Rozas et al., 1994; Li et al., 1994; Waga et al., 1994) . In contrast, p21 waf1 was without eect in an in vitro DNA-repair assay . This has led to the hypothesis that p21 waf1 can cause cells to arrest in S as well as in G1. Since the function of PCNA in DNA-repair is not aected this would allow repair to precede replication, and thus preventing replication of damaged DNA. Our ®ndings do not support such a function for p21 waf1 . When cells induced to express p21 waf1 for 24 h were pulsed with BrdU and BrdU-positive cells were followed in time by bivariate¯ow cytometry, cells seemed to progress through S normally, independent of the expression level of p21 waf1 . In these same cells, S-phase entry seemed to be inhibited, as well as progression through G2/M. In our view, it is unlikely that the cells in S-phase at 24 h after removal of tetracycline express insucient p21 waf1 . For one, CDK2-activity is fully inhibited at this timepoint, and secondly, these same cells arrest in G2 once they have completed this S-phase only a few hours later. These data indicate that p21 waf1 does not interfere with ongoing DNA-replication. Since p21 waf1 eciently inhibits CDK2-kinase activity in these cells this would mean that CDK2 plays no role in processive DNAreplication but could still be crucial for initiation. In addition, these data indicate that, although sucient p21 waf1 is available to fully inhibit CDK-activity, no eect is seen on the function of PCNA in processive DNA-replication in these cells. Again, it should be noted that these levels are very similar to those obtained by irradiation of the cells, suggesting that the S-phase delay that occurs after irradiation is not a consequence of the induction of p21 waf1 . The failure to detect any eect of p21 waf1 on DNA-replication in these cells could be explained by the fact that under these circumstances very little p21 waf1 appeared to be bound to PCNA. Such low levels of association would be expected to have no eect on DNA synthesis based on earlier reports made by others (Luo et al., 1995) . In those and other studies it was demonstrated that the eect of p21 waf1 on cyclin/ CDK activity is more consequential than its eect on the function of PCNA (Luo et al., 1995; Chen et al., 1995) . Based on these studies it was proposed that the mechanism of growth inhibition utilized by p21 waf1 depends on the relative abundance of CDKs versus PCNA. Therefore, the lack of association of p21 waf1 to PCNA could be due to high levels of cyclin/CDK complexes that titer out p21 waf1 . However, we would argue that since cyclin/CDK activity appears to be fully inhibited in our system that some excess p21
waf1 should be present in these cells available for association with PCNA. Possibly, binding of p21 waf1 to PCNA is prevented by some unknown mechanism in these cells. Indeed, interaction of p21 waf1 and PCNA was recently shown to be restricted to the G1 and G2 phase, p21 can block cells at two points in the cell cycle RH Medema et al suggesting that p21 waf1 cannot directly interact with PCNA during DNA replication (Savio et al., 1996) . Also, our ®ndings are consistent with the observations made using a dominant-negative mutant of p53 (Wyllie et al., 1996) . Expression of such a mutant in normal human diploid ®broblasts abrogated the G1-arrest and blocked the induction of p21 waf1 . However, the inhibition of DNA replication remained normal, indicating that this occurs independent of the p53/ p21 waf1 -pathway. One of the substrates of cyclin A/CDK2 complexes is the E2F-1 transcription factor. Phosphorylation of E2F-1 by cyclin A/CDK2 results in inhibition of the DNA-binding activity of E2F-1 and its ability to transactivate (Dynlacht et al., 1994; Krek et al., 1994) . Expression of mutants of E2F-1 unable to bind cyclin A/CDK2 in NIH3T3 ®broblasts caused an S-phase arrest followed by apoptosis, suggesting down-regulation of E2F-1 transcriptional activity is required for orderly progression through S (Krek et al., 1995) . Our ®nding that S-phase progression is normal when cyclin A/CDK2 activity is inhibited argues against such a model, or would suggest other mechanisms exist to down-regulate E2F-1 activity in S-phase. We are currently investigating the phosphorylation state of E2F in these cells.
Expression of physiological levels of p21 waf1 using these tetracycline-regulatable U2OS-derived cells causes them to arrest in the G1 and G2/M phases. This is most likely due to the ability of p21 waf1 to inhibit CDKactivity in G1 as well as in G2. The eect of p21 waf1 on G1/S progression had already been demonstrated in a variety of cells using transient transfection. However, using such assays it was not possible to determine whether p21 waf1 aected G2/M progression as well. Here we ®nd a clear eect of p21 waf1 -expression in the G2/M phases of the cell cycle. As mentioned, cells accumulate with a 2N and 4N DNA content after induction of p21 waf1 . It is unlikely that the increase in cells with a 4N DNA content is caused by tetraploid cells arrested in G1, since we ®nd very little BrdUpositive tetraploid cells at any time in these cultures. Also, when DNA synthesis was blocked using hydroxyurea less than 12% of the cells arrest with a 4N DNA content and when arrested with nocodazole we ®nd less than 2% of cells with an 8N DNA content. Therefore, the percentage of tetraploid cells in these tumor-derived cells is less than 10%. More evidence to support an eect of p21 waf1 on progression through G2/ M, comes from the BrdU pulse-chase experiment where we determined the fate of BrdU-positive cells in cultures induced to express p21 waf1 . Once those cells had completed S they did not progress normally through G2/M into the next G1-phase but remained somewhere in G2/M, clearly demonstrating this constitutes a true G2/M arrest.
Progression through G2/M depends on the activity of the cyclin B/CDC2 complex, which can be inhibited by p21 waf1 . Also, as mentioned above, p53 controls passage through G2/M through its involvement in the spindle checkpoint (Cross et al., 1995) . However, p21 waf1 does not seem to be required for this function of p53 (Brugarolas et al., 1995; Deng et al., 1995) . In addition, p21 waf1 was shown to be a potent inhibitor of G1/S cyclin/CDK complexes, but much less eective in inhibition of cyclin B/CDC2 kinase activity. In the light of those data it was somewhat unexpected that we ®nd an arrest in G2/M upon induction of expression of p21 waf1 . Therefore, we investigated the eect of high levels of p21 waf1 on cyclin B-associated kinase activity. Indeed, we found a very signi®cant reduction in kinase activity coming down in cyclin B immunoprecipitates from UTA21.15 cells grown in the absence of tetracycline. This inhibition was not due to a reduction in cyclin B expression as judged by Western blotting of total cell lysates from these same cells. Rather, the inhibition appeared to occur through direct binding of p21 waf1 to cyclin B, since cyclin B seemed to co-immunoprecipitate with p21 waf1 and vice versa. The data described in this paper clearly establish the role of p21 waf1 as inhibitor of CDKs and question its role as inhibitor of PCNA and SAPKs. In addition, the cell lines used in this study in which expression of p21 waf1 is regulated by a tetracycline-repressible promoter enable us to study the events in G1 and G2 that are dependent on activation of CDKs. We are currently studying the expression of several genes which are normally induced in mid-and late-G1 and are thought to require the activation of cyclin-kinase complexes. Hopefully this will help us to understand the sequence of events required for orderly progression through G1.
Materials and methods
Recombinant plasmids
The p21 waf1 human cDNA was obtained by PCR-amplification of a Hela cell cDNA library (a gift of C Sardet, IGM, Montpellier) using two oligonucleotide primers, a 5' primer (5'-GGAATTCACCACCATGTCAGAACCGGC-TG-3') and a 3'-primer (5'-GGAATTCCTGTGGGCG-GATTAG-3'). A 526 bp fragment was ampli®ed and puri®ed on a low melting agarose gel. The fragment was cloned into pGEM-T (Promega) and the p21 waf1 coding sequence was con®rmed by sequence analysis. The resulting plasmid was digested with EcoRI to excise the p21 waf1 coding region. This fragment was subsequently cloned into the EcoRI site of the tetracycline-repressible expression vector pUHD10-3 (provided by Drs M Gossen and H Bujard), to obtain pUHD10-3.p21 waf1 .
Cell culture and transfections UTA6 cells are derived from the human osteosarcoma cell line U2OS and stably express the tTA hybrid protein (kindly provided by Dr Christoph Englert, Forschungszentrum Karlsruhe, Germany) (Englert et al., 1995) . UTA6 cells were routinely grown in Dulbecco's Modi®ed Eagle Medium (DMEM) supplied with 10% fetal calf serum and 100 mg/ml G418. UTA6 cells were transfected using the standard calcium phosphate technique with 20 mg pUHD10-3 (for UTApuro1), or pUHD10-3.p21 waf1 plasmid (for UTA21.9 and UTA21.15) in combination with 2 mg pBabe.puro (Danos and Mulligan, 1988) . Twenty-four hours after transfection the medium was replaced with DMEM containing 1 mg/ml puromycin and 1 mg/ml tetracycline. Two weeks later individual colonies were picked and analysed for inducible expression of p21 waf1 . Cells were maintained in DMEM containing 10% fetal calf serum, 1 mg/ml puromycin and 1 mg/ml tetracycline. Prior to trypsinization cells were washed twice with phosphate buered saline (PBS) containing 1 mg/ml tetracycline. Tetracycline was routinely removed from the cultures by two washes of PBS, followed by trypsinization and replating the cells. UTApuro1 and UTA21.15 cells were cultured in the presence or absence of 1 mg/ml tetracycline for 72 h. Cells were then trypsinized and plated in 6 well plates and grown with or without 1 mg/ml tetracycline for 10 days. Cells were counted every day in a hematocytometer and the medium was changed every other day. For [ 3 H]thymidine incorporation cells were seeded in triplicate in a 24 well plate at a density of 50 000 cells per well and cultured in medium with or without 1 mg/ml tetracycline. forty-eight hours later [ 3 H]thymidine (1 mCi/ml) was added to the medium and cells were cultured for an additional 2 h. Cells were washed three times with PBS and ®xed in methanol for 2 h. Unincorporated [ 3 H]thymidine was removed by three washes with PBS. Subsequently DNA was hydrolyzed overnight in 0.2 N NaOH and the amount of incorporated [ 3 H]thymidine was determined in a liquid scintillation counter.
Western blotting and in vitro kinase reactions
For Western blotting cells were lysed directly in sample buer without b-mercaptoethanol and bromophenolblue. Protein concentrations were then determined, after which b-mercaptoethanol and bromophenolblue were added and samples were boiled for 5 min. Samples were separated on a polyacrylamide (PAA) gels and blotted to nitrocellulose membranes. p21 waf1 was detected using a rabbit polyclonal antibody (C-19, Santa Cruz), cyclin B with a mouse monoclonal (GSN1, Santa Cruz). Cells cultured in the presence or absence of 1 mg/ml tetracycline were washed twice with ice-cold PBS and lysed in E1A-lysis buer (ELB) (150 mM NaCl, 50 mM HEPES, pH 7.5, 5 mM EDTA, 0.1% NP-40 with 10 mM b-glycerophosphate, 5 mM NaF, 1 mM Na 2 VO 3 , 10 mg/ml aprotinin, leupeptin and trypsin inhibitor) at 48C. Lysates were cleared by centrifugation in an Eppendorf centrifuge at 14 000 r.p.m. at 48C. Supernatants were then precleared with 20 ml protein A sepharose (Pharmacia) for 30 min at 48C. Immunoprecipitation of CDK2 was performed overnight with 2 ml anti-CDK2 (M2, Santa Cruz), for immunoprecipitation of cyclin E we used 4 ml anti-cyclin E (HE111, Santa Cruz) and for cyclin B we used 4 ml anti-cyclin B (GSN1, Santa Cruz). Immunoprecipitates were washed three times with ELB and two times in kinase buer (20 mM HEPES, pH 7.5, 5 mM MgCl 2 , 2.5 mM MnCl 2 and 1 mM dithiothreitol). Immunocomplexes were subsequently incubated in kinase buer supplemented with 50 mM ATP, 2.5 mCi [g 32 -P]ATP (Amersham) and 10 mg of histone H1 (Boehringer Mannheim) for 30 min at 308C. In vitro kinase reactions for SAPK were done essentially as the CDK2 kinase reactions, except that immunoprecipitation was done using anti-SAPK from Santa Cruz (anti-JNK2 (FL)) and a slightly modi®ed kinase buer was used (25 mM HEPES pH 7.5, 20 mM MgCl 2 , 20 mM b-glycerophosphate, and 2 mM dithiothreitol). This kinase buer was supplemented with 10 mCi [g 32 -P]ATP and 10 mg GSTc-jun (a gift of P Coer, Utrecht University Hospital) as substrate. Kinase reactions were terminated by adding sample buer. Samples were separated on a 10% PAA gel and the phosphorylated histone H1 or GST-c-jun were visualized by autoradiography. Amount of incorporated 32 P was determined on a Phosphor-imager.
Cell cycle analysis
Replicative DNA synthesis and DNA content were analysed using bivariate¯ow cytometry. To this end, cells were pulsed with 1 mM BrdU for 10 min. Cells were harvested and ®xed overnight in 70% ethanol at 48C. After washing away the ethanol, cells were treated with 0.1 N HCl containing 0.4 mg/ml pepsine for 20 min at room temperature. Cells were then treated with 2 N HCl for 12 min at 378C, followed by addition of a 0.05 M borate buer (pH 9.0). The cells were washed and incubated with FITC-conjugated anti-BrdU antibodies (Becton-Dickinson) and counterstained with propidium iodide in a solution containing 10 mg/ml propidiumiodide and 10 mg/ml DNase-free RNaseA at 378C for 30 min. The stained cells were analysed on a¯uorescence-activated cell sorter (FACS) using Lysis II software¯ow cytometry analysis (Becton Dickinson).
For analysis of progression of cells through S-phase, cells were grown in the presence or absence of tetracycline for a period of 24 h. Cells were then pulsed with 1 mM BrdU for 10 min, after which BrdU was washed away from the cells and fresh medium with or without tetracycline was added to the cells. At dierent time-points after the BrdU-pulse, cells were harvested and prepared for cell cycle analysis as described above.
S-methionine labeling
Cells were washed twice with PBS and incubated in methionine-free medium for 30 min. This medium was then removed and fresh methionine-free medium was added. To this 35 S-methionine was added (Express label, Dupont/NEN) at a concentration of 0.06 mCi/ml and cells were grown for another 3 h. Cells were then lysed as for in vitro kinase reactions and immunoprecipitations were carried out similarly using equal amounts of counts per immunoprecipitation. For immunoprecipitation of PCNA we used a mouse monoclonal (Ab-1, Oncogene Science), for p21 waf1 a rabbit polyclonal (C-19, Santa Cruz), for cyclin B a mouse monoclonal (GSN1, Santa Cruz). Immunocomplexes were collected on protein A/G sepharose beads (Santa Cruz) and washed six times with ELB. Samples were then boiled and separated on a 8 ± 15% PAA gradient gel. Gels were ®xed and treated with Amplify (Amersham) before autoradiography. Bands were quanti®ed using a Phospho-imager.
